Literature DB >> 17146439

PML4 induces differentiation by Myc destabilization.

M Buschbeck1, I Uribesalgo, A Ledl, A Gutierrez, S Minucci, S Muller, L Di Croce.   

Abstract

Opposing functions like oncogene and tumor suppressions have been established for c-Myc and promyelocytic leukemia (PML) protein, respectively. Myc is known to inhibit differentiation of hematopoietic precursor cells, and here we report that PML promotes cell differentiation. We further demonstrate that PML and Myc form a complex in vivo. The interaction of the two proteins leads to the destabilization of Myc in a manner dependent on the really interesting new gene (RING) domain of PML. Although several PML isoforms are able to interact with Myc, the ability to destabilize Myc is specific for PML4. Importantly, the PML-induced destabilization resulted in a reduction of promoter-bound Myc on Myc-repressed genes. Thereby, PML induced the re-activation of Myc-repressed target genes including the tumor suppressive genes of the cell cycle inhibitors cdkn1a/p21 and cdkn2b/p15. Together, these results establish PML-mediated destabilization of Myc and the derepression of cell cycle inhibitor genes as an important regulatory mechanism that allows cell differentiation and prevents aberrant proliferation driven by uncontrolled Myc activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17146439     DOI: 10.1038/sj.onc.1210128

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  PML: An emerging tumor suppressor and a target with therapeutic potential.

Authors:  Erin L Reineke; Hung-Ying Kao
Journal:  Cancer Ther       Date:  2009-09-01

2.  Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner.

Authors:  Sue Haupt; Catherine Mitchell; Vincent Corneille; Jake Shortt; Stephen Fox; Pier Paolo Pandolfi; Mireia Castillo-Martin; Dennis M Bonal; Carlos Cordon-Cardo; Guillermina Lozano; Ygal Haupt
Journal:  Cell Cycle       Date:  2013-05-08       Impact factor: 4.534

3.  Growth-promoting and tumourigenic activity of c-Myc is suppressed by Hhex.

Authors:  V Marfil; M Blazquez; F Serrano; J V Castell; R Bort
Journal:  Oncogene       Date:  2014-09-15       Impact factor: 9.867

4.  Cellular senescence and protein degradation: breaking down cancer.

Authors:  Xavier Deschênes-Simard; Frédéric Lessard; Marie-France Gaumont-Leclerc; Nabeel Bardeesy; Gerardo Ferbeyre
Journal:  Cell Cycle       Date:  2014-05-27       Impact factor: 4.534

5.  MacroH2A1 regulates the balance between self-renewal and differentiation commitment in embryonic and adult stem cells.

Authors:  Catherine Creppe; Peggy Janich; Neus Cantariño; Marc Noguera; Vanesa Valero; Eva Musulén; Julien Douet; Melanija Posavec; Juan Martín-Caballero; Lauro Sumoy; Luciano Di Croce; Salvador A Benitah; Marcus Buschbeck
Journal:  Mol Cell Biol       Date:  2012-02-13       Impact factor: 4.272

6.  E-box-independent regulation of transcription and differentiation by MYC.

Authors:  Iris Uribesalgo; Marcus Buschbeck; Arantxa Gutiérrez; Sophia Teichmann; Santiago Demajo; Bernd Kuebler; Josep F Nomdedéu; Juan Martín-Caballero; Guglielmo Roma; Salvador Aznar Benitah; Luciano Di Croce
Journal:  Nat Cell Biol       Date:  2011-10-23       Impact factor: 28.824

7.  Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells.

Authors:  Erin L Reineke; Minh Lam; Qing Liu; Yu Liu; Kristopher J Stanya; Kun-Sang Chang; Anthony R Means; Hung-Ying Kao
Journal:  Mol Cell Biol       Date:  2007-11-26       Impact factor: 4.272

8.  MBD3, a component of the NuRD complex, facilitates chromatin alteration and deposition of epigenetic marks.

Authors:  Lluis Morey; Carmen Brenner; Francesco Fazi; Raffaella Villa; Arantxa Gutierrez; Marcus Buschbeck; Clara Nervi; Saverio Minucci; Francois Fuks; Luciano Di Croce
Journal:  Mol Cell Biol       Date:  2008-07-21       Impact factor: 4.272

9.  Promyelocytic leukemia protein controls cell migration in response to hydrogen peroxide and insulin-like growth factor-1.

Authors:  Erin L Reineke; Yu Liu; Hung-Ying Kao
Journal:  J Biol Chem       Date:  2010-01-25       Impact factor: 5.157

10.  Differential Roles of PML Isoforms.

Authors:  Sébastien Nisole; Mohamed Ali Maroui; Xavier H Mascle; Muriel Aubry; Mounira K Chelbi-Alix
Journal:  Front Oncol       Date:  2013-05-22       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.